東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Development of Third-Generation Gold...

Varma Gottimukkala, Karthikeya Srinivasa,

Linked to FindBook

Google Book

Amazon

博客來

Development of Third-Generation Gold Nanoparticles (CRISPR-AuNP) for Enhanced CRISPR Delivery to Hematopoietic Stem and Progenitor Cells /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Development of Third-Generation Gold Nanoparticles (CRISPR-AuNP) for Enhanced CRISPR Delivery to Hematopoietic Stem and Progenitor Cells // Karthikeya Srinivasa Varma Gottimukkala.
Author:	Varma Gottimukkala, Karthikeya Srinivasa,
Description:	1 electronic resource (122 pages)
Notes:	Source: Dissertations Abstracts International, Volume: 87-01, Section: B.
Contained By:	Dissertations Abstracts International87-01B.
Subject:	Nanotechnology. -
Online resource:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=32114138
ISBN:	9798288824913

Development of Third-Generation Gold Nanoparticles (CRISPR-AuNP) for Enhanced CRISPR Delivery to Hematopoietic Stem and Progenitor Cells /
Varma Gottimukkala, Karthikeya Srinivasa,

Development of Third-Generation Gold Nanoparticles (CRISPR-AuNP) for Enhanced CRISPR Delivery to Hematopoietic Stem and Progenitor Cells /Karthikeya Srinivasa Varma Gottimukkala. - 1 electronic resource (122 pages)

Source: Dissertations Abstracts International, Volume: 87-01, Section: B.

Efficient CRISPR ribonucleoprotein (RNP) delivery into hematopoietic stem and progenitor cells (HSPC, CD34+) enables stable genome editing with potential for lifelong therapeutic benefits from a single intervention. However, current methods like electroporation require specialized equipment and procedures, whereas viral vectors are costly and require living cells to assemble, limiting access in research and clinical translation. Synthetic nanoparticles offer a promising alternative. We previously reported a gold-based CRISPR-AuNP nanoformulation that delivered gene editing in HSPCs, favoring Cas12a over Cas9. Here, we demonstrate that Cas9 loads poorly into this formulation. By elucidating Cas9's physicochemical interactions with AuNP surfaces, we optimized the nanoformulation by pre-forming RNP complexes in a 2nd generation CRISPR-AuNP. This formulation demonstrated increased active Cas9 and Cas12a loading in tube but failed to deliver gene editing in primary cells in vitro. Further analysis of the CRISPR-AuNP physiochemistry with HPSC endosomes guided further optimization. Preformed RNP polyplexes were formed with thiolated poly(ethyleneimine)-poly(ethylene glycol) (PEI-PEG-SH) polymers at a 2 N/P ratio and conjugated to AuNP. This 3rd generation Cas9 CRISPR-AuNP achieved 13.23 ± 0.12% indels at the β-2-microglobulin (B2M) gene in HSPCs at a 100 pmol dose, with no observed loss in cell viability and cell entry within 6 hours. The platform's modularity extended to two additional CRISPR systems: Cas12a (15.07 ± 1.9% indels) and MG29-1 (13.39 ± 1.5% indels), highlighting its versatility. Most importantly, this nanoformulation can be assembled in a few hours at benchtop for <$70 per 1 million HSPC treated. We also demonstrate early data that this formulation can be modified with surface antibodies to facilitate active cellular targeting, with a future goal of testing these formulations in vivo for possible clinical translation. Very preliminary in vivo studies using untargeted 3rd generation Cas9 CRISPR-AuNP targeting the murine B2m gene in wild-type C57Bl6 mice showed detectable gene editing in multiple tissues with no elevated inflammatory responses or increased liver enzymes. These advancements position gold-polymeric nanoparticle hybrids as a simple, low-cost non-viral delivery system for CRISPR into HSPCs. The ability to rapidly assemble these particles with different CRISPR systems and polymers will greatly increase research access for multiple cell types.

English

ISBN: 9798288824913Subjects--Topical Terms:

526235
Nanotechnology.
Subjects--Index Terms:

Gene editing

Development of Third-Generation Gold Nanoparticles (CRISPR-AuNP) for Enhanced CRISPR Delivery to Hematopoietic Stem and Progenitor Cells /
LDR:04088nmm a22004453i 4500 001 2434926
005 20251001062557.5
006 m o d
007 cr|nu||||||||
008 261011s2025 miu||||||m |||||||eng d
020 $a 9798288824913
035 $a (MiAaPQD)AAI32114138
035 $a AAI32114138
040 $a MiAaPQD $b eng $c MiAaPQD $e rda
100 1 $a Varma Gottimukkala, Karthikeya Srinivasa, $e author. $3 3825074
245 1 0 $a Development of Third-Generation Gold Nanoparticles (CRISPR-AuNP) for Enhanced CRISPR Delivery to Hematopoietic Stem and Progenitor Cells / $c Karthikeya Srinivasa Varma Gottimukkala.
264 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2025
300 $a 1 electronic resource (122 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 87-01, Section: B.
500 $a Advisors: Adair, Jennifer E. Committee members: Warren, Edus Houston; Lieber, Andre; Polyak, Stephen J.; Gao, Xiaohu.
502 $b Ph.D. $c University of Washington $d 2025.
520 $a Efficient CRISPR ribonucleoprotein (RNP) delivery into hematopoietic stem and progenitor cells (HSPC, CD34+) enables stable genome editing with potential for lifelong therapeutic benefits from a single intervention. However, current methods like electroporation require specialized equipment and procedures, whereas viral vectors are costly and require living cells to assemble, limiting access in research and clinical translation. Synthetic nanoparticles offer a promising alternative. We previously reported a gold-based CRISPR-AuNP nanoformulation that delivered gene editing in HSPCs, favoring Cas12a over Cas9. Here, we demonstrate that Cas9 loads poorly into this formulation. By elucidating Cas9's physicochemical interactions with AuNP surfaces, we optimized the nanoformulation by pre-forming RNP complexes in a 2nd generation CRISPR-AuNP. This formulation demonstrated increased active Cas9 and Cas12a loading in tube but failed to deliver gene editing in primary cells in vitro. Further analysis of the CRISPR-AuNP physiochemistry with HPSC endosomes guided further optimization. Preformed RNP polyplexes were formed with thiolated poly(ethyleneimine)-poly(ethylene glycol) (PEI-PEG-SH) polymers at a 2 N/P ratio and conjugated to AuNP. This 3rd generation Cas9 CRISPR-AuNP achieved 13.23 ± 0.12% indels at the β-2-microglobulin (B2M) gene in HSPCs at a 100 pmol dose, with no observed loss in cell viability and cell entry within 6 hours. The platform's modularity extended to two additional CRISPR systems: Cas12a (15.07 ± 1.9% indels) and MG29-1 (13.39 ± 1.5% indels), highlighting its versatility. Most importantly, this nanoformulation can be assembled in a few hours at benchtop for <$70 per 1 million HSPC treated. We also demonstrate early data that this formulation can be modified with surface antibodies to facilitate active cellular targeting, with a future goal of testing these formulations in vivo for possible clinical translation. Very preliminary in vivo studies using untargeted 3rd generation Cas9 CRISPR-AuNP targeting the murine B2m gene in wild-type C57Bl6 mice showed detectable gene editing in multiple tissues with no elevated inflammatory responses or increased liver enzymes. These advancements position gold-polymeric nanoparticle hybrids as a simple, low-cost non-viral delivery system for CRISPR into HSPCs. The ability to rapidly assemble these particles with different CRISPR systems and polymers will greatly increase research access for multiple cell types.
546 $a English
590 $a School code: 0250
650 4 $a Nanotechnology. $3 526235
650 4 $a Molecular biology. $3 517296
650 4 $a Bioengineering. $3 657580
653 $a Gene editing
653 $a Gold nanoparticles
653 $a Non viral vectors
653 $a Stem cells
653 $a Transfection
653 $a Nanoformulation
690 $a 0652
690 $a 0307
690 $a 0202
710 2 $a University of Washington. $b Laboratory Medicine and Pathology. $e degree granting institution. $3 3825075
720 1 $a Adair, Jennifer E. $e degree supervisor.
773 0 $t Dissertations Abstracts International $g 87-01B.
790 $a 0250
791 $a Ph.D.
792 $a 2025
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=32114138